Medicine and Dentistry
ST Segment Elevation Myocardial Infarction
100%
Primary Percutaneous Coronary Intervention
90%
Percutaneous Aortic Valve Replacement
58%
Acute Heart Infarction
44%
Fibrinolysis
44%
Heart Valve
43%
Percutaneous Coronary Intervention
41%
Sick Sinus Syndrome
37%
Angioplasty
32%
Aortic Valve
29%
Infarction
26%
Apoplexy
25%
Thrombosis
21%
Transluminal Coronary Angioplasty
21%
Symptom
19%
Multidetector Computed Tomography
18%
Percutaneous Aortic Valve
17%
Hazard Ratio
17%
Patient Referral
15%
Heart Failure
15%
Isotopes of Calcium
14%
Diabetes Mellitus
14%
Ventricular Outflow Tract
12%
Reperfusion Therapy
10%
Aortic Valve Prosthesis
10%
Myocardial Infarction
10%
Triage
10%
Injury
9%
Therapy Delay
9%
Abciximab
8%
Troponin T
8%
Aortic Insufficiency
8%
Rapamycin
8%
Aortic Root
8%
Transesophageal Echocardiography
8%
Diagnosis
7%
Heart Atrium Pacing
7%
Combination Therapy
7%
Fibrinolytic Therapy
7%
Noninferiority Trial
7%
Randomized Clinical Trial
7%
Paclitaxel
7%
PQ Interval
7%
Paroxysmal Atrial Fibrillation
7%
Time to Treatment
7%
Magnesium
7%
Anterior Myocardial Infarction
7%
Prosthetic Valve Endocarditis
7%
Heart Graft
7%
Everolimus
7%
Pharmacology, Toxicology and Pharmaceutical Science
ST Segment Elevation Myocardial Infarction
87%
Acute Heart Infarction
44%
Infarction
21%
Heart Infarction
19%
Symptom
18%
Abciximab
15%
Fibrinolytic Therapy
14%
Diabetes Mellitus
14%
Sick Sinus Syndrome
14%
Heparin
12%
Population Study
10%
Stent Thrombosis
10%
Enoxaparin
7%
Supraventricular Tachycardia
7%
Artery Lesion
7%
Normal Human
7%
Heart Ventricle Tachycardia
7%
Everolimus
7%
Noninferiority Trial
7%
Paclitaxel
7%
Patent Foramen Ovale
7%
Hypercholesterolemia
7%
Rapamycin
7%
Randomized Controlled Trial
7%
Thrombosis
7%
Disease Predisposition
7%
Anterior Myocardial Infarction
7%
Pregnancy Associated Plasma Protein A
7%
Umirolimus
7%
Cardiogenic Shock
7%
Heart Disease
7%
Reteplase
5%